The European Medicines Agency (EMA) reiterated on Thursday that the AstraZeneca vaccine was “Safe and effective” and was “not associatedAt a higher risk of blood clots – however, specifying that “The vaccine can be associated with very rare cases of blood clots linked to thrombocytopenia, that is to say to a low level of blood platelets (elements present in the blood which help it to clot) with or without bleeding , including rare cases of clots in the vessels draining blood from the brain ”.
About 30 cases of blood clots in people recently vaccinated with the Swedish-British product AstraZeneca had been reported to the EMA in recent weeks, causing
–
Vaccine Coronavirus The Covid-19 pandemic in France– .